159 related articles for article (PubMed ID: 9818289)
1. Interests of the 'artificial stomach' techniques to study antacid formulations: comparison with in vivo evaluation.
Vatier J; Célice-Pingaud C; Farinotti R
Fundam Clin Pharmacol; 1998; 12(6):573-83. PubMed ID: 9818289
[TBL] [Abstract][Full Text] [Related]
2. [In vitro evaluation of antacid activity in gastric acid secretion in static and dynamic systems].
Vatier J; Malikova-Sekera E; Vitre MT; Mignon M
Therapie; 1992; 47(2):99-104. PubMed ID: 1412150
[TBL] [Abstract][Full Text] [Related]
3. An artificial stomach-duodenum model for the in-vitro evaluation of antacids.
Vatier J; Malikova-Sekera E; Vitre MT; Mignon M
Aliment Pharmacol Ther; 1992 Aug; 6(4):447-58. PubMed ID: 1420737
[TBL] [Abstract][Full Text] [Related]
4. Antacid activity of calcium carbonate and hydrotalcite tablets. Comparison between in vitro evaluation using the "artificial stomach-duodenum" model and in vivo pH-metry in healthy volunteers.
Vatier J; Ramdani A; Vitré MT; Mignon M
Arzneimittelforschung; 1994 Apr; 44(4):514-8. PubMed ID: 8011006
[TBL] [Abstract][Full Text] [Related]
5. A model of an 'artificial stomach' for assessing the characteristics of an antacid.
Vatier J; Lionnet F; Vitré MT; Mignon M
Aliment Pharmacol Ther; 1988 Oct; 2(5):461-70. PubMed ID: 2979268
[TBL] [Abstract][Full Text] [Related]
6. In vitro assessment of antacid efficacy using a computer-controlled 'artificial stomach-duodenum' model reproducing gastroduodenal flux regulation.
Vatier J; Cai S; Célice-Pingaud C; Castela-Papin N; Mignon M; Farinotti R
Therapie; 1996; 51(2):147-54. PubMed ID: 8763049
[TBL] [Abstract][Full Text] [Related]
7. [pH gradient support and antacid action of gastroesophageal coating agents. In vitro pharmacologic study using a model of "the artificial stomach"].
Vatier J; Vitre MT; Vallot T; Mignon M
Gastroenterol Clin Biol; 1990; 14(5):414-22. PubMed ID: 2163935
[TBL] [Abstract][Full Text] [Related]
8. Interactions of cimetidine and ranitidine with aluminum-containing antacids and a clay-containing gastric-protective drug in an "artificial stomach-duodenum" model.
Vatier J; Harman A; Castela N; Droy-Lefaix MT; Farinotti R
J Pharm Sci; 1994 Jul; 83(7):962-6. PubMed ID: 7965675
[TBL] [Abstract][Full Text] [Related]
9. Assessment of antacid characteristics of drugs containing a combination of aluminium and magnesium salts using the "artificial stomach" model.
Vatier J; Vitre MT; Lionnet F; Poitevin C; Mignon M
Arzneimittelforschung; 1990 Jan; 40(1):42-8. PubMed ID: 2339999
[TBL] [Abstract][Full Text] [Related]
10. Methods for the assessment of antacids. In-vitro and in-vivo investigations with gastric aspiration.
Keyriläinen O
Scand J Gastroenterol Suppl; 1982; 75():40-3. PubMed ID: 6959249
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the interaction between antacid and gastric mucosa using an "artificial stomach" model including gastric mucosa.
Vatier JL; Gao Z; Fu-Cheng XM; Vitre MT; Levy DA; Cohen G; Mignon M
J Pharmacol Exp Ther; 1992 Dec; 263(3):1206-11. PubMed ID: 1469628
[TBL] [Abstract][Full Text] [Related]
12. [Antacid action of the aluminum cation: comparison of the in vitro effect of hydroxide and phosphate in open and closed systems].
Vatier J; Lionnet F; Vitre MT
Gastroenterol Clin Biol; 1987 Nov; 11(11):758-63. PubMed ID: 3428519
[TBL] [Abstract][Full Text] [Related]
13. Fate of oral neutralizing antacid and its effect on postprandial gastric secretion and emptying.
Deering TB; Carlson GL; Malagelada JR; Duenes JA; McCall JT
Gastroenterology; 1979 Nov; 77(5):986-90. PubMed ID: 39873
[TBL] [Abstract][Full Text] [Related]
14. New approach for the in vitro evaluation of antacids.
Vatier J; Vallot T; Vitre MT; Mignon M
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):175-9. PubMed ID: 2185759
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the antacid properties of Gelox in a dynamic milieu using the artificial stomach apparatus].
Vatier J; Vitre MT; Lionnet F; Mignon M
Therapie; 1989; 44(1):43-8. PubMed ID: 2734720
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of the antacid effect of some commonly consumed foods for hyperacidity in an artificial stomach model.
Panda V; Shinde P; Deora J; Gupta P
Complement Ther Med; 2017 Oct; 34():111-115. PubMed ID: 28917362
[TBL] [Abstract][Full Text] [Related]
17. Fate of antacid gel in the stomach. Site of action and interaction with food.
Bauerfeind P; Cilluffo T; Armstrong D; Emde C; Müller-Duysing W; Duroux P; Blum AL
Dig Dis Sci; 1990 May; 35(5):553-8. PubMed ID: 2331951
[TBL] [Abstract][Full Text] [Related]
18. [Intragastric utilization of antacids following meals in relation to stomach emptying].
Lux G; Hartog C; Ruppin H; Lederer P; Schmitt W
Z Gastroenterol; 1983 Mar; 21 Suppl():41-9. PubMed ID: 6858410
[TBL] [Abstract][Full Text] [Related]
19. Two placebo-controlled crossover studies in healthy subjects to evaluate gastric acid neutralization by an alginate-antacid formulation (Gaviscon Double Action).
Wilkinson J; Abd-Elaziz K; den Daas I; Wemer J; van Haastert M; Hodgkinson V; Foster M; Coyle C
Drug Dev Ind Pharm; 2019 Mar; 45(3):430-438. PubMed ID: 30470147
[TBL] [Abstract][Full Text] [Related]
20. [Antacid activity of citrate-bicarbonate complex of effervescent formulations of ranitidine. In vitro analysis using 'artificial stomach-duodenum' model].
Vatier J; Cai S; Slama A; Farinotti R
Therapie; 1996; 51(2):139-46. PubMed ID: 8763048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
